Studying cancer-related fatigue: Report of the NCCN scientific research committee

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 8, Issue 12, 2010, Pages 1331-1339

  Mortimer, Joanne E ^a   Barsevick, Andrea M ^b   Bennett, Charles L ^c   Berger, Ann M ^d   Cleeland, Charles ^e   DeVader, Shannon R ^f   Escalante, Carmen ^g   Gilreath, Jeffrey ^h   Hurria, Arti ^a   Mendoza, Tito R ^g   Rugo, Hope S ⁱ  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d NEBRASKA MEDICAL CENTER   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f National Comprehensive Cancer Network   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h UNIVERSITY OF UTAH   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer related fatigue; Fatigue assessment; Treatable contributing factors to fatigue

Indexed keywords

DEXAMETHASONE; HEMOPOIETIC GROWTH FACTOR; METHYLPHENIDATE; MODAFINIL;

BREAST CANCER; CANCER FATIGUE; CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); COGNITIVE THERAPY; DATA BASE; DISTRESS SYNDROME; EDUCATION; FEMALE; HUMAN; PAIN ASSESSMENT; PATIENT ASSESSMENT; PHYSICAL ACTIVITY; QUESTIONNAIRE; REVIEW; SELF REPORT; SLEEP;

EID: 78951492796     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2010.0101     Document Type: Review

References (49)

1. Barsevick AM, Cleeland CS, Manning DC, et al. ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manage 2010;39:1086-1099.
2. Berger A, Abernethy A, Atkinson A, et al. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Cancer-Related Fatigue. Version 1.2010. Available at: www.NCCN.org. Last accessed November 10, 2010.
3. Cella D, Davis K, Breitbart W, Curt G. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a united states sample of cancer survivors. J Clin Oncol 2001;19:3385-3391.
4. Sadler IJ, Jacobsen PB, Booth-Jones M, et al. Preliminary evaluation of a clinical syndrome approach to assessing cancer-related fatigue. J Pain Symptom Manage 2002;23:406-416.
5. Loscalzo MJ, Clark KL. Problem-related distress in cancer patients drives requests for help: a prospective study. Oncology (Williston Park) 2007;21:1133-1138.
6. So WK, Marsh G, Ling WM, et al. The symptom cluster of fatigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer: a multicenter study. Oncol Nurs Forum 2009;36:E205-214.
7. Gaston-Johansson F, Fall-Dickson JM, Bakos AB, Kennedy MJ. Fatigue, pain, and depression in pre-autotransplant breast cancer patients. Cancer Pract 1999;7:240-247.
8. Dittner AJ, Wessely SC, Brown RG. The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res 2004;56:157-170.
9. Wu H, McSweeney M. Measurement of fatigue in people with cancer. Oncol Nurs Forum 2001;28:1371-1384.
10. Hjollund NH, Andersen JH, Bech P. Assessment of fatigue in chronic disease: a bibliographic study of fatigue measurement scales. Health Qual Life Outcomes 2007;5:12.
11. Jacobsen PB. Assessment of fatigue in cancer patients. J Natl Cancer Inst Monogr 2004;32:93-97.
12. Jean-Pierre P, Figueroa-Moseley CD, Kohli S, et al. Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist 2007;12:11-21.
13. Minton O, Stone P. A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Ann Oncol 2009;20:17-25.
14. Broderick JE, Schwartz JE, Vikingstad G, et al. The accuracy of pain and fatigue items across different reporting periods. Pain 2008;139:146-157.
15. Yancik R. Cancer burden in the aged: an epidemiologic and demographic overview. Cancer 1997;80:1273-1283.
16. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56:M146-156.
17. Kangas M, Bovbjerg DH, Montgomery GH. Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull 2008;134:700-741.
18. Cramp F, Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 2008:CD006145.
19. Goedendorp M, Gielissen M, Verhagen C, Bleijenberg G. Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst Rev 2009:CD006953.
20. Jacobsen P, Donovan K, Vadaparampil S, Small B. Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue. Health Psychol 2007;26:660-667.
21. American Society of Clinical Oncology. Coping with cancerrelated fatigue. Available at: http://www.cancer.net/patient/ All+About+Cancer/Cancer. Net+Feature+Articles/Side+Effects/Coping+With+Cancer-Related+Fatigue. Accessed November 10, 2010.
22. Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME. Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol 2005;23:1431-1438.
23. Davidson J, MacLean A, Brundage M, Schulze K. Sleep disturbance in cancer patients. Soc Sci Med 2002;54:1309-1321.
24. Escalante C, Manzullo E. Cancer-related fatigue: the approach and treatment. J Gen Intern Med 2009;24:412-416.
25. Epstein D, Dirksen S. Randomized trial of a cognitive-behavioral intervention for insomnia in breast cancer survivors. Oncol Nurs Forum 2007;34:E51-59.
26. Espie CA, Fleming L, Cassidy J, et al. Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol 2008;26:4651-4658.
27. Sarhill N, Walsh D, Nelson K, et al. Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study. Am J Hosp Palliat Care 2001;18:187-192.
28. Bruera E, Valero V, Driver L, et al. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 2006;24:2073-2078.
29. Lower E, Fleishman S, Cooper A, et al. A phase III, randomized placebo-controlled trial of the safety and efficacy of d-MPH as new treatment of fatigue and "chemobrain" in adult cancer patients [abstract]. J Clin Oncol 2005;23(Suppl 1):Abstract 8000.
30. Minton O, Richardson A, Sharpe M, et al. A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst 2008;100:1155-1166.
31. Moraska AR, Sood A, Dakhil SR, et al. Phase III, randomized, doubleblind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial. J Clin Oncol 2010;28:3673-3679.
32. Provigil [package insert]. Frazer, PA: Cepahlon; 2009.
33. Morrow G, Gillies L, Hickok J, et al. The positive effect of the psychostimulant modafinil on fatigue from cancer that persists after treatment is completed [abstract]. J Clin Oncol 2005;23(Suppl 1):Abstract 8012.
34. Morrow G, Jean-Pierre P, Roscoe J, et al. A phase III randomized, placebo-controlled, double-blind trial of a eugeroic agent in 642 cancer patients reporting fatigue during chemotherapy: a URCC CCOP study [abstract]. J Clin Oncol 2008;26(Suppl 1):Abstract 9512.
35. Spathis A, Dhillan R, Booden D, et al. Modafinil for the treatment of fatigue in lung cancer: a pilot study. Palliat Med 2009;23:325-331.
36. Blackhall L, Petroni G, Shu J, et al. A pilot study evaluating the safety and efficacy of modafinil for cancer-related fatigue. J Palliat Med 2009;12:433-439.
37. Moertel C, Schutt A, Reitemeier R, Hahn R. Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer 1974;33:1607-1609.
38. Della Cuna GR, Pellegrini A, Piazzi M. Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group. Eur J Cancer Clin Oncol 1989;25:1817-1821.
39. Juneja V, Keegan P, Gootenberg J, et al. Continuing reassessment of the risks of erythropoiesis-stimulating agents in patients with cancer. Clin Cancer Res 2008;14:3242-3247.
40. Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients. Cancer 1999;85:1186-1196.
41. Welstein L, Dement W, Redington D, Guilleminault C. Insomnia in the San Francisco Bay Area: a telephone survey. In: Guilleminault C, Lugaresi E, eds. Sleep/Wake Disorders: Natural History, Epidemiology, and Long-Term Evolution. New York, NY: Raven Press; 1983:73-85.
42. Swarm R, Abernethy A, Anghelescu DL, et al. NCCN Clinical Practice Guidelines in Oncology: Adult Cancer Pain. Version 1.2010. Available at: http://www.nccn.org/professionals/physician-gls/PDF/pain.pdf. Accessed November 10, 2010.
43. Holland JC, Andersen B, Breitbart WS, et al. NCCN Clinical Practice Guidelines in Oncology: Distress Management. Version 1.2011. Available at: http://www.nccn.org/professionals/physician-gls/PDF/distress.pdf . Accessed November 10, 2010.
44. California Teachers Study. Available at: http://www.calteachersstudy.org/ surveys.html. Accessed November 10, 2010.
45. Ryan JL, Carroll JK, Ryan EP, et al. Mechanisms of cancer-related fatigue. Oncologist 2007;12:22-34.
46. Stasi R, Abriani L, Beccaglia P, et al. Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer 2003;98:1786-1801.
47. Yellen SB, Cella DF, Webster K, et al. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 1997;13:63-74.
48. McNair D, Lorr M. EITS Manual for the Profile of Mood States. San Diego, CA: Education and Testing Service; 1971.
49. Piper B, Dibble S, Dodd M, et al. The Revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 1998;25:677-684.